Sheng Xu

A set-aware latent transport model predicts treated cell populations from unpaired controls, keeps perturbation-specific signal in CRISPR, drug and cytokine data, and guided a cytokine choice tested in three donors.

π-PrimeNovo is a non-autoregressive deep learning model for de novo peptide sequencing that achieves higher accuracy and 69x faster performance than existing methods.